Health-Related Quality of Life Outcomes for the LEAP Study - CALGB 70305 (Alliance): A Lymphedema Prevention Intervention Trial for Newly Diagnosed Breast Cancer Patients
- Citation:
- Cancer vol 127 (2) 300-9
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 10
- Parents:
- 2948
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Health Outcomes
- Sec. Committees:
- Symptom Inter
- Pharmas:
- Grants:
- UG1CA189823, UG1CA189860, UG1CA189817, UG1CA189819, U10CA180790, U10CA180836, U10CA180850, P30CA033572, UL1TR001409
- Corr. Author:
- Authors:
- Michelle J. Naughton Heshan Liu Drew Seisler Jennifer Le-Rademacher Jane M. Armer Jill M. Oliveri Jeffrey A. Sloan Karen Hock Michael Schwartz Gary Unzeitig Marianne Melnik Lisa D. Yee Gini F. Fleming John R. Taylor Charles Loprinzi Electra D. Paskett
- Networks:
- CA043, CRCWM, LAPS-IL057, LAPS-MN026, LAPS-OH007, MO036, NY213, TX190
- Study
- CALGB-70305
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: